Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Kae609
2. Nitd 609
3. Nitd-609
4. Nitd609
1. 1193314-23-6
2. Nitd609
3. Nitd 609
4. Nitd-609
5. Kae609
6. Cipargamin [inn]
7. 1252008-89-1
8. Spiro[3h-indole-3,1'-[1h]pyrido[3,4-b]indol]-2(1h)-one, 5,7'-dichloro-6'-fluoro-2',3',4',9'-tetrahydro-3'-methyl-, (1'r,3's)-
9. Z7q4fwa04p
10. (3r,3's)-5,7'-dichloro-6'-fluoro-3'-methylspiro[1h-indole-3,1'-2,3,4,9-tetrahydropyrido[3,4-b]indole]-2-one
11. Chembl1082723
12. Kae-609
13. (1'r,3's)-5,7'-dichloro-6'-fluoro-3'-methyl-2',3',4',9'-tetrahydrospiro[indoline-3,1'-pyrido[3,4-b]indol]-2-one
14. Rel-(1'r,3's)-5,7'-dichloro-6'-fluoro-3'-methyl-2',3',4',9'-tetrahydrospiro[indoline-3,1'-pyrido[3,4-b]indol]-2-one
15. Unii-z7q4fwa04p
16. Spiro(3h-indole-3,1'-(1h)pyrido(3,4-b)indol)-2(1h)-one, 5,7'-dichloro-6'-fluoro-2',3',4',9'-tetrahydro-3'-methyl-, (1'r,3's)-
17. Cipargamin [who-dd]
18. Gtpl9721
19. Schembl1306342
20. Dtxsid70152424
21. Bdbm50318666
22. Mfcd25976667
23. Zinc49037032
24. Cs-7486
25. Db12306
26. Nitd-609, (+)-
27. Ncgc00263785-01
28. As-51977
29. Hy-14430
30. P14044
31. Q6954404
32. (1'r,3's)-5,7'-dichloro-6'-fluoro-2',3',4',9'-tetrahydro-3'-methyl-spiro[3h-indole-3,1'-[1h]pyrido[3,4-b]indol]-2(1h)-one
33. (1'r,3's)-5,7'-dichloro-6'-fluoro-2',3',4',9'-tetrahydro-3'-methylspiro[3h-indole-3,1'-[1h]pyrido[3,4-b]indol]-2(1h)-one
34. (1r,3s)-5'',7-dichloro-6-fluoro-3-methyl-2,3,4,9-tetrahydrospiro-[beta-carboline-1,3''-indol]-2''(1''h)-one
35. (1r,3s)-5',7-dichloro-6-fluoro-3-methyl-spiro[2,3,4,9-tetrahydropyrido[3,4-b]indole-1,3'-indoline]-2'-one
36. (1r,3s)-5,7-dichloro-6-fluoro-3-methyl-2,3,4,9-tetrahydrospiro[indoline-3,1-pyrido[3,4-b]indol]-2-one
| Molecular Weight | 390.2 g/mol |
|---|---|
| Molecular Formula | C19H14Cl2FN3O |
| XLogP3 | 3.9 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 0 |
| Exact Mass | 389.0497956 g/mol |
| Monoisotopic Mass | 389.0497956 g/mol |
| Topological Polar Surface Area | 56.9 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 609 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
14
PharmaCompass offers a list of Cipargamin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cipargamin manufacturer or Cipargamin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cipargamin manufacturer or Cipargamin supplier.
PharmaCompass also assists you with knowing the Cipargamin API Price utilized in the formulation of products. Cipargamin API Price is not always fixed or binding as the Cipargamin Price is obtained through a variety of data sources. The Cipargamin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cipargamin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cipargamin, including repackagers and relabelers. The FDA regulates Cipargamin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cipargamin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cipargamin supplier is an individual or a company that provides Cipargamin active pharmaceutical ingredient (API) or Cipargamin finished formulations upon request. The Cipargamin suppliers may include Cipargamin API manufacturers, exporters, distributors and traders.
Cipargamin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cipargamin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cipargamin GMP manufacturer or Cipargamin GMP API supplier for your needs.
A Cipargamin CoA (Certificate of Analysis) is a formal document that attests to Cipargamin's compliance with Cipargamin specifications and serves as a tool for batch-level quality control.
Cipargamin CoA mostly includes findings from lab analyses of a specific batch. For each Cipargamin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cipargamin may be tested according to a variety of international standards, such as European Pharmacopoeia (Cipargamin EP), Cipargamin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cipargamin USP).
